Know Labs, Inc.
About: Know Labs Inc is a medical diagnostic. The company is focused on the development, marketing, and sales of proprietary technologies that are capable of uniquely identifying or authenticating almost any substance or material using electromagnetic energy to record, detect, and identify the signature of the substance or material known as Bio-RFID and ChromaID technologies. It is developing a wearable device that will measure blood glucose without fingersticks or microneedles.
Employees: 7
0
Funds holding %
of 7,407 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
0.24% less ownership
Funds ownership: 3.58% [Q3] → 3.34% (-0.24%) [Q4]
6% less funds holding
Funds holding: 32 [Q3] → 30 (-2) [Q4]
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
44% less capital invested
Capital invested by funds: $1.11M [Q3] → $617K (-$488K) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for KNW.
Financial journalist opinion
Neutral
Business Wire
1 month ago
Know Labs Sensor Non-Invasively Identifies pH Levels in Real Time
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) is pleased to announce that it has completed extensive research in its laboratory utilizing its patented Radio Frequency Dielectric Spectroscopy (RFDS) sensor technology to identify changes in pH levels in real time. The research has been submitted for peer reviewed publication. The research is available for review today here on the Company's website at www.knowlabs.co. An abstract of the paper states, “We describe an experiment in.
Neutral
Business Wire
1 month ago
Know Labs to Attend the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology with its Radio Frequency Dialectic Spectroscopy (RFDS) platform, today announced the company will be attending The 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) Technology Fair in Amsterdam, Netherlands on March 19-22, 2025. The Company will share updates on the development of its non-invasive blood glucose monitor, sin.
Neutral
Business Wire
1 month ago
Know Labs Announces Cancellation of Special Meeting of Stockholders
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (previously NYSE American: KNW, now OTC Pink Markets: KNWN), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS), announced today the cancellation of the Special Meeting of Stockholders previously scheduled for March 7, 2025 (Special Meeting), which was intended to seek approval for a reverse stock split. The Company's decision to cancel the Special Meeting comes after the Company announced a 1 for 40.
Neutral
Business Wire
1 month ago
Know Labs Announces Reverse Stock Split Effective February 19, 2025
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (previously NYSE American: KNW, now OTC Pink Markets: KNWN), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS), announced today a 1 for 40 reverse stock split of its authorized and issued and outstanding shares of common stock. The reverse stock split was announced on February 18, 2025. The reverse stock split will be effective as of the morning of February 19, 2025, and the Company's common stock w.
Neutral
Business Wire
2 months ago
Know Labs, Inc. to Report First Quarter FY 2025 Results
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (previously NYSE American: KNW, now OTC Markets: KNWN), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS) for non-invasive medical diagnostic technology and diverse other fields of use through its newly initiated Know Labs Technology Licensing (KTL) initiative, today reported financial results for the first quarter of the fiscal year 2025. Financial Highlights: In Q1 FY 2025, Know Labs reported a ne.
Neutral
Business Wire
2 months ago
Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2025 Results on February 14, 2025
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (previously NYSE American: KNW, now OTC Markets: KNWN), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS) for non-invasive medical diagnostic technology and diverse other fields of use through its newly initiated Know Labs Technology Licensing (KTL) initiative, today announced it will host a webcast to review business updates and results for its first quarter of the fiscal year 2025 ended on Decembe.
Neutral
Business Wire
2 months ago
Know Labs Files Appeal to NYSE Commencement of Proceedings to Delist
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (previously NYSE American: KNW, now OTC Markets: KNWN), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS), announced today it has filed an appeal of the NYSE American's commencement of proceedings to delist Know Labs from its exchange. The Company will continue working on certain curative actions to regain compliance to maintain its listing while it awaits its appeal to the Listings Qualifications P.
Neutral
Business Wire
2 months ago
Know Labs Responds to NYSE Commencement of Proceedings to Delist
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS), announced today it is working on certain curative actions to regain compliance to maintain its listing and appeal the NYSE's determination to delist its common stock to the Listings Qualifications Panel of the Exchange. The company's stock will be suspended from trading on the NYSE American during this time. NYSE Regulation is.
Neutral
Business Wire
2 months ago
NYSE American to Commence Delisting Proceedings Against Know Labs, Inc. (KNW)
NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Know Labs, Inc. (the “Company”) — ticker symbol KNW — from NYSE American. Trading in the Company's common stock will be suspended immediately. NYSE Regulation has determined that the Company is no longer suitable for listing pursuant to Section 1003(f)(v) of the NYSE American Company Guide due to t.
Neutral
Business Wire
2 months ago
Know Labs Launches Know Labs Technology Licensing (KTL)
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS), is proud to announce the formation of its new business unit, Know Labs Technology Licensing, (KTL). Modeled after the successful Qualcomm Technology Licensing (QTL) framework, KTL will be dedicated to licensing Know Labs' robust intellectual property (IP) portfolio to corporate partners, academic institutions and research organ.
Charts implemented using Lightweight Charts™